APA

Gerber D. E., Urbanic J. J., Langer C., Hu C., Chang I., Lu B., Movsas B., Jeraj R., Curran W. J. & Bradley J. D. (20180309). Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505). : Clinical lung cancer.

Chicago

Gerber David E, Urbanic James J, Langer Corey, Hu Chen, Chang I-Fen, Lu Bo, Movsas Benjamin, Jeraj Robert, Curran Walter J and Bradley Jeffrey D. 20180309. Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505). : Clinical lung cancer.

Harvard

Gerber D. E., Urbanic J. J., Langer C., Hu C., Chang I., Lu B., Movsas B., Jeraj R., Curran W. J. and Bradley J. D. (20180309). Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505). : Clinical lung cancer.

MLA

Gerber David E, Urbanic James J, Langer Corey, Hu Chen, Chang I-Fen, Lu Bo, Movsas Benjamin, Jeraj Robert, Curran Walter J and Bradley Jeffrey D. Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505). : Clinical lung cancer. 20180309.